ArticlePharmacoepidemiology and drug safety2026

Methodological Challenges of Emulating a Target Trial to Assess Effectiveness of Timing of PCSK9 Inhibitor Treatment Initiation Post Myocardial Infarction.

Thomas Cars et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.